01Oct 2023
A twenty year perspective on melanoma therapy

A twenty year perspective on melanoma therapy

Despite substantial progress in melanoma treatment between 2010 and 2014, recent advancements have slowed, with challenges in addressing resistance to BRAF/MEK and immune checkpoint therapies. While PD-1 antibodies transformed treatment, new therapeutic classes are deemed essential for significant patient outcome improvements. This slowdown contrasts the remarkable gains made in melanoma outcomes during the 2010s.

  • #dermatology

Like

Save

Share